MACERICH CO (MAC)
Macerich Announces Pricing of Upsized Offering of $675 Million Exchangeable Senior Notes due 2031
Macerich Announces Pricing of Upsized Offering of $675 Million Exchangeable Senior Notes due 2031
McChip Announces Board and Management Changes
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
Construction Partners, Inc. Announces Fiscal 2026 Third Quarter Results
Kimbell Royalty Partners Announces Record Second Quarter 2026 Results
THE WENDYS COMPANY REPORTS SECOND QUARTER 2026 RESULTS
ARKO Corp. Reports Second Quarter 2026 Results
Federal Realty Announces Pricing of $400 Million of Exchangeable Senior Notes
Purple Biotech Reports Second Quarter 2026 Financial Results